An organ transplantation enterprise, Genext, applied for the IPO again after the termination two years ago. On November 24, 2022, the IPO of Genext was accepted by the Shanghai Stock Exchange Science and Technology Innovation Board.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
